N4 Pharma appoints David Solomon as CEO
UK biotech N4 Pharma, a company developing a gene delivery system to enable advanced therapies for cancer and other diseases, has appointed David Solomon as Chief Executive Officer (CEO). David brings over 30 years of international leadership experience in …